Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
Stocks in this Quantisnow insightHealth Care
Historical context for CLDX
Across the 20 sessions after earlier CLDX headlines, the stock closed higher 10 times and lower 10 times, with a median move of 2.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CLDX | SPY |
|---|---|---|---|
| May 8, 2026 | Celldex Reports First Quarter Financial Results and Provides Corporate Update | +2.0% | +0.8% |
| Apr 20, 2026 | Celldex Therapeutics upgraded by Barclays with a new price target | -0.5% | -0.2% |
| Apr 14, 2026 | Celldex to Present at Upcoming Investor Conference | +2.3% | +1.2% |
| Apr 6, 2026 | Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares | +1.0% | +0.5% |
| Apr 2, 2026 | Celldex Announces Pricing of $300 Million Public Offering of Common Stockand 1 other headline that session | -0.6% | +0.1% |
| Mar 27, 2026 | Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026 | -4.6% | -1.7% |
Keep researching CLDX
- CLDX insider tradesEvery buy and sale reported by Celldex Therapeutics Inc. officers, directors and large holders.
- CLDX earnings historyPast Celldex Therapeutics Inc. earnings releases, newest first.
- CLDX financial statementsRevenue, profit, cash flow and balance sheet from Celldex Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
CLDX
Celldex Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
Get push alerts for CLDX
Full CLDX profile on Quantisnow Follow CLDX and get a push notification the moment its next story breaks.